Could This Pill Be the Key to Eternal Youth?
Eternal youth? No. Delay of aging diseases? Maybe.
“Could this pill be the key to eternal youth?”
That was a question posed by a London Telegraph headline about ten days ago.
The pill in question is metformin, a medication already used by millions of people with Type 2 diabetes and approved by Health Canada over 40 years ago.
Now researchers are suggesting that metformin may be helpful not only in prolonging life for people with diabetes but also for everyone by controlling sugar in the body as we age, thereby delaying the onset diseases of aging such as cardiovascular disease, Alzheimer’s and cancer.
The research has been ongoing for a couple of years and it’s clearly no magic bullet or fountain of youth.
But the story was nevertheless picked up by the National Post this week with this headline:
A clinical trial on humans approved by the U.S. Federal Drug Administration and spearheaded by Dr. Nir Barzilai, directing of the Institute, will determine whether metformin can delay the onset of age-related diseases.
“Initial observational results in a U.K. clinical study and extensive animal research are promising,” reports the Einstein College.
What is also noteworthy is that it’s the first time the FDA has approved a clinical trial of a drug that may help prolong health as people age.
“Should the trial prove successful,” suggests the Einstein report, “it could revolutionize how the FDA evaluates medications, encourage pharmaceutical companies to invest in new therapies targeting aging, and improve the healthcare economics of old age.”
Clearly, this isn’t the magic pill that will extend middle age to 98 or keep us in the gym ’til 118. But whether it’s metformin or the development of another drug that helps to keep us healthier as we age, that news is exciting enough without hyping the idea of “eternal youth” and a “cure for Alzheimer’s,” both of which are false interpretations of the research.